DiaGen AI  /  News

Announced milestones.

December 2023 to date. Full releases are available at diagen.ai/news and via EIN Presswire.

Collaboration and revenue share agreement with Hadassah Medical Organization and Ariel University

Read more →

Life sciences and AI expert Aditya Tallapragada appointed to the advisory board

Read more →

Study published: biomarker integration and biosensor tech enabling AI-driven insights in biological aging

Read more →
Chosen again as a Top 100 Canadian tech company
Exhibiting at ALL IN AI Montreal
—
Sep 16, 2025
JV with Contango Labs
First decentralized drug discovery miner on Bittensor $TAO
—
May 23, 2025
Partnership with Mila
Scaling protein design in diagnostics and drug discovery
—
Nov 7, 2024
Research collaboration with the Structural Genomics Consortium
UNC Chapel Hill
—
Jun 27, 2024
Frontier IP announces stake in DiaGen AI
Including the TVG collaboration
—
May 2, 2024
Unit financing and auditor appointment
Davidson & Company LLP named independent auditor
—
Mar 6, 2024
Partnership with The Vaccine Group
Cambridge, UK — co-developing novel vaccines
—
Jan 30, 2024
Proteic Biosciences Inc. renamed DiaGen AI Inc.
New CEO, new website, corporate update
—
Dec 13, 2023

Tech-Bio Partnering: Tools and Deployment

For platform access, catalog partnering or co-development enquiries.

[email protected]